Latest Health News
Millions Face Soaring ACA Marketplace Premiums in 2026
Middle-class Americans with Affordable Care Act plans confront skyrocketing premiums for 2026, prompting some to reconsider coverage. Trump's proposed healthcare plan avoids addressing these Obamacare cost increases directly. ACA enrollment ends soon in most states amid Democratic pushes for no-premium options.
US Signs $11 Billion Health Aid Deals with 16 African Nations
The State Department negotiates billions in health aid to replace USAID's dismantled system, signing agreements with 16 African countries for over $11 billion over five years. More deals pending in Asia, Latin America. This 'America First' strategy raises concerns over transparency and implementation.
US Nursing Home Capacity Drops 15% Due to Staffing Shortages
Nursing home capacity has declined significantly since COVID-19, limiting long-term care access and delaying hospital discharges. University of Rochester research highlights impacts in JAMA Internal Medicine. Staffing shortages are the primary driver.
Lyme Disease Costs US Up to $1 Billion Annually
A new study estimates Lyme disease imposes substantial costs, mainly from cases progressing beyond early infection. Financial burden affects patients and healthcare system alike. Retrospective cohort analysis underscores need for early intervention.
Measles Cases Surge in US with 2,242 Reported in 2025
Measles, once eliminated, saw its largest US outbreak in decades due to declining vaccine rates and hesitancy, with cases in multiple states including North Carolina. Outbreaks hit Texas, New Mexico, Utah, South Carolina. High vaccination coverage is critical to curb spread.
Novartis Ianalumab Gets FDA Breakthrough for Sjögren's Disease
FDA grants Breakthrough Therapy designation to ianalumab based on phase III trials showing reduced disease activity. The monoclonal antibody targets B-cells via BAFF-R blockade for this unmet autoimmune need. Global submissions planned for early 2026.
Key 2026 Drug Launches: Oveporexton for Narcolepsy, Bemarituzumab for Gastric Cancer
Takeda's first-in-class orexin-2 agonist oveporexton targets narcolepsy; Amgen's bemarituzumab hits FGFR2b in gastric cancer. Novo Nordisk's CagriSema for obesity and Moderna's mRNA-1083 combo vaccine also highlighted. These launches could reshape markets.
HHS Reverses Cuts to Mental Health Funding Amid Chaos
HHS abruptly reversed $2 billion cuts to mental health and addiction services after backlash. This follows policy instability, including cancelled hepatitis B vaccine studies in Africa. FY26 budget advances restore some global health funds.
Statins Linked to Longer Life in All Type 2 Diabetes Patients
UK study shows statins reduce deaths and cardiac events across all heart risk levels in type 2 diabetes patients. Benefits hold regardless of low predicted risk. Findings suggest broader statin use recommendation.
UN Declaration Sets 2030 Targets for NCDs Despite US Opposition
UN General Assembly adopts declaration with 175 countries in favor, targeting tobacco reduction, hypertension control, mental health access by 2030. US and Argentina voted against. Shapes global health action on noncommunicable diseases.
Purdue mRNA Delivery System Advances Bladder Cancer Therapy
Patent-pending virus-mimicking platform improves mRNA targeting of bladder cancer cells, enhancing expression and stability. Published in PNAS, it offers better encapsulation and green manufacturability. Targets upregulated receptors effectively.
Once-Weekly Oral HIV Regimen Shows Strong 48-Week Results
Investigational once-weekly oral HIV treatment demonstrates robust efficacy at 48 weeks. Highlights need for simpler options to improve adherence. Presented January 16, advancing easier HIV management.